IP Library Granted Patent US 10,052,415
Granted Patent B2
US 10,052,415 · App. 15/173,376 · Granted Aug 21, 2018

Tropoelastin for promoting endothelial cell adhesion or migration

Inventors: Dean Y. Li (Salt Lake City, UT); Brent D. Wilson (Salt Lake City, UT); Lise Sorensen Brunhart (Salt Lake City, UT)
Assignee: University of Utah Research Foundation
A61L31/16A61K38/39A61L27/227A61L27/34A61L27/3808A61L27/3895A61L27/54A61L29/048A61L29/085A61L29/16A61L31/047A61L31/10A61N1/362A61N1/3956A61L2300/416A61L2300/42A61L2300/61A61L2400/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,052,415
App. No.
15/173,376
Granted
Aug 21, 2018
Kind
B2
Abstract

The invention provides methods, compositions, and devices for promoting adhesion or migration of endothelial cell.

Claims (14)

1. An implantable medical device coated with a fragment of human tropoelastin, wherein said fragment consists of 17 consecutive amino acids and has at least 80% amino acid sequence identity to the amino acid sequence of SEQ ID NO: 6.

2. The device of claim 1 , wherein the human tropoelastin fragment is covalently attached to the device.

3. The device of claim 1 , wherein the human tropoelastin fragment is in an amount effective to promote adhesion of endothelial cells to the device.

4. The device of claim 3 , wherein the endothelial cells are endothelial stem cells or endothelial progenitor cells.

5. The device of claim 3 , wherein the amount of the human tropoelastin fragment is at least 100 ng per square centimeter.

6. The device of claim 1 , comprising a metal, an alloy or a plastic.

7. The device of claim 6 , wherein the metal comprises stainless steel.

8. The device of claim 1 , further comprising a biocompatible polymer.

9. The device of claim 8 , wherein the biocompatible polymer is selected from the group consisting of dacron, polyurethane, polypropylene, or polytetrafluoroethylene (PTFE).

10. The device of claim 1 , further comprising an anti-CD34 antibody.

11. The device of claim 10 , wherein the anti-CD34 antibody is monoclonal.

12. The device of claim 1 , wherein the device is a catheter, stent, shunt, wire, or other intraluminal device.

13. The device of claim 1 , wherein the device is a pacemaker, cardioverter-defibrillator, artificial valve, or vascular graft.

14. The device of claim 1 , comprising metal, plastic, silicone, dacron, polyurethane, polypropylene, PTFE, or derivatives thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2018
From: LI, DEAN Y.; WILSON, BRENT D.; BRUNHART, LISE SORENSEN
To: UNIVERSITY OF UTAH RESEARCH FOUNDATION
Reel/Frame 044741/0056 →
CONFIRMATORY LICENSE Recorded Dec 14, 2016
From: UNIVERSITY OF UTAH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 040939/0815 →
Continuity (4)
Continuation 14446973 · Jul 30, 2014
Continuation 11885105
Provisional Application 60656360 · Feb 25, 2005
Related Publication 20160346440A1 · Dec 1, 2016